LAG3 antibody (N-Term)
Quick Overview for LAG3 antibody (N-Term) (ABIN1169104)
Target
See all LAG3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- N-Term
-
Specificity
- Recognizes human LAG-3.
-
Cross-Reactivity
- Human
-
Purity
- >95 % (SDS-PAGE)
-
Endotoxin Level
- <0.001EU/μg purified protein or <1EU/mg purified protein (LAL test, Lonza).
-
Immunogen
- Synthetic peptide corresponding to 30 aa in the N-terminus of human LAG-3.
-
Isotype
- IgG1
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- In PBS.
-
Preservative
- Without preservative
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Short Term Storage: +4°C
Long Term Storage: -20°C
Stable for at least 1 year after receipt when stored at -20°C. -
Expiry Date
- 12 months
-
-
- LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
-
Alternative Name
- LAG-3
-
Background
- Lymphocyte activation gene 3 (LAG-3, CD223) plays an important role in negatively regulating T cell proliferation, function and homeostasis. It is required for maximal natural and induced regulatory T cell (Treg) function. LAG-3 is closely related to the T cell co-receptor CD4 and binds to MHC class II molecules but with a significantly higher affinity than CD4.
-
UniProt
- P18627
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Target
-